4-(2H-Tetrazol-5-yl)benzamide | 92712-51-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-(2H-Tetrazol-5-yl)benzamide
• CAS: 92712-51-1
• 化学式: C₈H₇N₅O
• 分子量: 189.17
• InChiKey: YJKFNKRQUHQHEC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  97.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(2H-Tetrazol-5-yl)benzamide 在 三乙胺 、 morpholine-iodine complex 作用下， 以 N,N-二甲基甲酰胺 、 苯 为溶剂， 反应 19.0h， 生成 2-(1'-iodopropyn-3'-yl)-5-(p-carbamoylphenyl)tetrazole
  参考文献：
  名称：

  Synthesis and quantitative structure-activity relationship analysis of N-triiodoallyl- and N-iodopropargylazoles. New antifungal agents

  摘要：

  New series of N-(2,3,3-triiodoallyl) and N-(3-iodopropargyl) azole derivatives (100 compounds) involving pyrrole, pyrazole, imidazole, triazole, and tetrazole nuclei were synthesized successively with the aid of quantitative structure-activity relationship (QSAR) analysis to obtain potent antifungal agents. Starting from the derivatives of nitropyrrole-containing antibiotics, the QSAR analysis of the pyrrole derivatives against Candida albicans and Trichophyton mentagrophytes strains indicated the positive contribution of the nitro group and negative effect of the size of molecule. Further application of the QSAR analysis on the multi-azole derivatives revealed the importance of hydrophobicity and electronegativity as well as steric effect to the activities and led to the synthesis of one of the most potent iodo compounds, 2-(2,3,3-triiodoallyl)tetrazole (67, ME1401).

  DOI：

  10.1021/jm00386a019
• 作为产物：
  描述：

  4-氰基苯甲酰胺 在 sodium azide 、 氯化铵 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 生成 4-(2H-Tetrazol-5-yl)benzamide
  参考文献：
  名称：

  Synthesis and quantitative structure-activity relationship analysis of N-triiodoallyl- and N-iodopropargylazoles. New antifungal agents

  摘要：

  New series of N-(2,3,3-triiodoallyl) and N-(3-iodopropargyl) azole derivatives (100 compounds) involving pyrrole, pyrazole, imidazole, triazole, and tetrazole nuclei were synthesized successively with the aid of quantitative structure-activity relationship (QSAR) analysis to obtain potent antifungal agents. Starting from the derivatives of nitropyrrole-containing antibiotics, the QSAR analysis of the pyrrole derivatives against Candida albicans and Trichophyton mentagrophytes strains indicated the positive contribution of the nitro group and negative effect of the size of molecule. Further application of the QSAR analysis on the multi-azole derivatives revealed the importance of hydrophobicity and electronegativity as well as steric effect to the activities and led to the synthesis of one of the most potent iodo compounds, 2-(2,3,3-triiodoallyl)tetrazole (67, ME1401).

  DOI：

  10.1021/jm00386a019

文献信息

• Novel indolyl derivatives which are L-CPT1 inhibitors
  申请人：Ackermann Jean

  公开号：US20070060567A1

  公开（公告）日：2007-03-15

  The invention is concerned with novel heterobicyclic derivatives of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.

  这项发明涉及式(I)的新异双环衍生物： 其中R1、R2、R3、R4、R5、R6、R7、A、X和Y的定义如描述和权利要求中所述，以及其生理上可接受的盐和酯。这些化合物抑制L-CPT1，可用作药物。
• Novel bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
  申请人：Ackermann Jean

  公开号：US20070191603A1

  公开（公告）日：2007-08-16

  The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , V, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.

  这项发明涉及公式（I）的新异双环衍生物，其中R1、R2、R3、R4、R5、R6、V、W、X和Y的定义如描述和索赔中所述，以及其生理上可接受的盐和酯。这些化合物抑制L-CPT1，可用作药物。
• Substituted Pyrrolidine-2-Carboxamides
  申请人：Ding Qingjie

  公开号：US20100075948A1

  公开（公告）日：2010-03-25

  There are provided compounds of the formula wherein X, Y, R 1 , R 2 , R 3 , R 3 , R 4 , R 5 , R 6 and R 7 are as described herein and enantiomers and pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents.

  提供了以下式的化合物 其中X、Y、R1、R2、R3、R3、R4、R5、R6和R7如本文所述，以及其对映体和药用可接受的盐和酯。这些化合物可用作抗癌药物。
• Design and Synthesis of 3-(2-Ethyl-4-{2-[2-(4-fluorophenyl)-5-methyloxazol-4-yl]ethoxy}phenyl)propanoic Acid: A Novel Triple-acting PPARα, -γ, and -δ Agonist
  作者：Qijun Zhang、Peng Sun、Guojun Zheng、Yaping Wang、Xiangjing Wang、Hegeng Wei、Wensheng Xiang

  DOI：10.1246/cl.2012.406

  日期：2012.4.5

  The design and synthesis of triple-acting PPARα, -γ, and -δ agonist 3-(2-ethyl-4-2-[2-(4-fluorophenyl)-5-methyloxazol-4-yl]ethoxy}phenyl)propanoic acid (1a) is described. The compound possesses a potent triple-acting PPARα, -γ, and -δ agonist profile with an EC50 of 0.029, 0.013, and 0.029 µM, respectively. The synthetic route, involving the synthesis of oxazole rings as the key step, starts from commercially available 3-oxopentanoic acid methyl ester and 3-hydroxyacetophenone to afford the target compound 1 with an overall yield of 32%.

  本文描述了三重作用PPARα、-γ和-δ激动剂3-(2-乙基-4-2-[2-(4-氟苯基)-5-甲基噁唑-4-基]乙氧基}苯基)丙酸(1a)的设计与合成。该化合物具有强大的三重作用PPARα、-γ和-δ激动剂特性，其EC50值分别为0.029、0.013和0.029 µM。合成路线以噁唑环的合成为关键步骤，从市售的3-氧代戊酸甲酯和3-羟基苯乙酮出发，最终得到目标化合物1，总产率为32%。
• INDAZOLE DERIVATIVES
  申请人：Ackermann Jean

  公开号：US20080103182A1

  公开（公告）日：2008-05-01

  The invention is concerned with novel indazole derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used in the prevention or treatment of diseases which are modulated by L-CPT1 inhibitors.

  这项发明涉及公式（I）的新型吲唑衍生物，其中R1、R2、R3、R4、R5、R6、X和Y的定义如描述和索赔中所述，以及其生理上可接受的盐和酯。这些化合物抑制L-CPT1，可用于预防或治疗受L-CPT1抑制剂调节的疾病。